NCT03955991 2025-06-26
VSMART
University of Miami
Phase 4 Completed
Clinical Trials
13 trialsNCT06124131 2025-05-04
BENEFIT-C
Tulane University
Phase NA Completed
NCT04080531 2025-02-28
Influenza Vaccination for Flu Prevention in Patients With Plasma Cell Disorders
Emory University
Phase 4 Completed
NCT02860039 2024-10-22
High Dose Flu Vaccine in Treating Children Who Have Undergone Donor Stem Cell Transplant
Vanderbilt-Ingram Cancer Center
Phase 2 Completed
NCT04484532 2023-06-06
Evaluation of Antibody Response to High-Dose Seasonal Influenza Vaccination in Patients With Myeloid Malignancy Receiving Chemotherapy and Healthy Volunteers
Roswell Park Cancer Institute
Phase EARLY_PHASE1 Completed
NCT02998736 2022-12-28
PERIOP-04
Ottawa Hospital Research Institute
Phase 1 Completed
NCT04591379 2022-12-13
Intratumoral Influenza Vaccine for Early Colorectal Cancer
Zealand University Hospital
Phase 2 Completed
NCT03590808 2019-09-19
Influenza Vaccination in Patients Receiving Immune Checkpoint Inhibitor
Seoul National University Hospital
Phase NA Completed
NCT02566265 2019-01-30
SHIVERING 2
Yale University
Phase 2 Completed
NCT01205581 2016-09-23
Immunogenicity of Fluzone HD,A High Dose Influenza Vaccine, In Children With Cancer or HIV
St. Jude Children's Research Hospital
Phase 2 Completed
NCT01666782 2016-06-24
IMMUNE
Rochester General Hospital
Phase 2 Completed
NCT00022035 2013-01-31
Vaccine Therapy in Preventing Flu in Children With Acute Lymphoblastic Leukemia
Roswell Park Cancer Institute
Phase NA Completed
NCT01031719 2012-09-13
Clinical Trial to Compare the Immunogenicity, Safety, and Tolerability of an Adjuvanted A(H1N1) Influenza Vaccine Versus Non-Adjuvanted A(H1N1) Influenza Vaccines in Patients With Invasive Solid Tumors
Chiltern Pesquisa Clinica Ltda
Phase 3 Completed